{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:37:37Z","timestamp":1791578257176,"version":"4.3.4"},"reference-count":220,"publisher":"National Institute for Health and Care Research","issue":"4","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/non-commercial-government-licence\/non-commercial-government-licence.htm"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["10\/142\/01"],"award-info":[{"award-number":["10\/142\/01"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"Background<\/jats:title>Tourette syndrome (TS) is a neurodevelopmental condition characterised by chronic motor and vocal tics affecting up to 1% of school-age children and young people and is associated with significant distress and psychosocial impairment.<\/jats:p><\/jats:sec>Objective<\/jats:title>To conduct a systematic review of the benefits and risks of pharmacological, behavioural and physical interventions for tics in children and young people with TS (part 1) and to explore the experience of treatment and services from the perspective of young people with TS and their parents (part 2).<\/jats:p><\/jats:sec>Data Sources<\/jats:title>For the systematic reviews (parts 1 and 2), mainstream bibliographic databases, The Cochrane Library, education, social care and grey literature databases were searched using subject headings and text words for tic* and Tourette* from database inception to January 2013.<\/jats:p><\/jats:sec>Review\/research methods<\/jats:title>For part 1, randomised controlled trials and controlled before-and-after studies of pharmacological, behavioural or physical interventions in children or young people (aged <\u200918 years) with TS or chronic tic disorder were included. Mixed studies and studies in adults were considered as supporting evidence. Risk of bias associated with each study was evaluated using the Cochrane tool. When there was sufficient data, random-effects meta-analysis was used to synthesize the evidence and the quality of evidence for each outcome was assessed using the Grading of Recommendations Assessment, Development and Evaluation approach. For part 2, qualitative studies and survey literature conducted in populations of children\/young people with TS or their carers or in health professionals with experience of treating TS were included in the qualitative review. Results were synthesized narratively. In addition, a national parent\/carer survey was conducted via the Tourettes Action website. Participants included parents of children and young people with TS aged under 18 years. Participants (young people with TS aged 10\u201317 years) for the in-depth interviews were recruited via a national survey and specialist Tourettes clinics in the UK.<\/jats:p><\/jats:sec>Results<\/jats:title>For part 1, 70 studies were included in the quantitative systematic review. The evidence suggested that for treating tics in children and young people with TS, antipsychotic drugs [standardised mean difference (SMD) \u20130.74, 95% confidence interval (CI) \u20131.08 to \u20130.41;n<\/jats:italic>\u2009=\u200975] and noradrenergic agents [clonidine (Dixarit\u00ae<\/jats:sup>, Boehringer Ingelheim) and guanfacine: SMD \u20130.72, 95% CI \u20131.03 to \u20130.40;n<\/jats:italic>\u2009=\u2009164] are effective in the short term. There was little difference among antipsychotics in terms of benefits, but adverse effect profiles do differ. Habit reversal training (HRT)\/comprehensive behavioural intervention for tics (CBIT) was also shown to be effective (SMD \u20130.64, 95% CI \u20130.99 to \u20130.29;n<\/jats:italic>\u2009=\u2009133). For part 2, 295 parents\/carers of children and young people with TS contributed useable survey data. Forty young people with TS participated in in-depth interviews. Four studies were in the qualitative review. Key themes were difficulties in accessing specialist care and behavioural interventions, delay in diagnosis, importance of anxiety and emotional symptoms, lack of provision of information to schools and inadequate information regarding medication and adverse effects.<\/jats:p><\/jats:sec>Limitations<\/jats:title>The number and quality of clinical trials is low and this downgrades the strength of the evidence and conclusions.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>Antipsychotics, noradrenergic agents and HRT\/CBIT are effective in reducing tics in children and young people with TS. The balance of benefits and harms favours the most commonly used medications: risperidone (Risperdal\u00ae<\/jats:sup>, Janssen), clonidine and aripiprazole (Abilify\u00ae<\/jats:sup>, Otsuka). Larger and better-conducted trials addressing important clinical uncertainties are required. Further research is needed into widening access to behavioural interventions through use of technology including mobile applications (\u2018apps\u2019) and video consultation.<\/jats:p><\/jats:sec>Study registration<\/jats:title>This study is registered as PROSPERO CRD42012002059.<\/jats:p><\/jats:sec>Funding<\/jats:title>The National Institute for Health Research Health Technology Assessment programme.<\/jats:p><\/jats:sec>","DOI":"10.3310\/hta20040","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T13:46:47Z","timestamp":1453384007000},"page":"1-450","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":118,"title":["Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis"],"prefix":"10.3310","volume":"20","author":[{"given":"Chris","family":"Hollis","sequence":"first","affiliation":[{"name":"Division of Psychiatry and Applied Psychology, Institute of Mental Health, University of Nottingham Innovation Park, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Pennant","sequence":"additional","affiliation":[{"name":"National Collaborating Centre for Mental Health, Royal College of Psychiatrists, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Cuenca","sequence":"additional","affiliation":[{"name":"Division of Psychiatry and Applied Psychology, Institute of Mental Health, University of Nottingham Innovation Park, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cris","family":"Glazebrook","sequence":"additional","affiliation":[{"name":"Division of Psychiatry and Applied Psychology, Institute of Mental Health, University of Nottingham Innovation Park, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Kendall","sequence":"additional","affiliation":[{"name":"National Collaborating Centre for Mental Health, Royal College of Psychiatrists, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Whittington","sequence":"additional","affiliation":[{"name":"National Collaborating Centre for Mental Health, Royal College of Psychiatrists, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Stockton","sequence":"additional","affiliation":[{"name":"National Collaborating Centre for Mental Health, Royal College of Psychiatrists, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linn\u00e9a","family":"Larsson","sequence":"additional","affiliation":[{"name":"National Collaborating Centre for Mental Health, Royal College of Psychiatrists, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Bunton","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, University of Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Dobson","sequence":"additional","affiliation":[{"name":"Tourettes Action, The Meads Business Centre, Farnborough, Hampshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Groom","sequence":"additional","affiliation":[{"name":"Division of Psychiatry and Applied Psychology, Institute of Mental Health, University of Nottingham Innovation Park, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Hedderly","sequence":"additional","affiliation":[{"name":"Paediatric Neurology Department, Kings College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isobel","family":"Heyman","sequence":"additional","affiliation":[{"name":"Department of Child and Adolescent Mental Health, Great Ormond Street Hospital for Children, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina M","family":"Jackson","sequence":"additional","affiliation":[{"name":"Division of Psychiatry and Applied Psychology, Institute of Mental Health, University of Nottingham Innovation Park, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Jackson","sequence":"additional","affiliation":[{"name":"School of Psychology, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Murphy","sequence":"additional","affiliation":[{"name":"Institute of Neurology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Rickards","sequence":"additional","affiliation":[{"name":"National Centre for Mental Health, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Robertson","sequence":"additional","affiliation":[{"name":"Department of Neurology, St George\u2019s University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Stern","sequence":"additional","affiliation":[{"name":"Tourettes Action, The Meads Business Centre, Farnborough, Hampshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2016,1]]},"reference":[{"key":"key20160120090146612_ref1-bib1","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders. DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"key20160120090146612_ref1-bib2","volume-title":"International Classification of Diseases and Health-Related Problems","author":"World Health Organization (WHO)","year":"1992"},{"key":"key20160120090146612_ref1-bib3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1192\/bjp.154.2.147","article-title":"The Gilles de la Tourette syndrome: the current status","volume":"154","author":"Robertson","year":"1989","journal-title":"Br J Psychiatry"},{"key":"key20160120090146612_ref1-bib4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1469-7610.1994.tb01209.x","article-title":"Annotation: Gilles de la Tourette syndrome \u2013 an update","volume":"35","author":"Robertson","year":"1994","journal-title":"J Child Psychol Psychiatry"},{"key":"key20160120090146612_ref1-bib5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1017\/S0033291700024211","article-title":"Self-injurious behaviour and the Gilles de la Tourette syndrome: a clinical study and review of the literature","volume":"19","author":"Robertson","year":"1989","journal-title":"Psychol Med"},{"key":"key20160120090146612_ref1-bib6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1176\/jnp.8.3.311","article-title":"Non\u2013obscene complex socially inappropriate behavior in Tourette\u2019s syndrome","volume":"8","author":"Kurlan","year":"1996","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"key20160120090146612_ref1-bib7","volume-title":"Gilles de la Tourette Syndrome: The Current Status","author":"Robertson","year":"2013"},{"key":"key20160120090146612_ref1-bib8","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1212\/WNL.53.9.2108","article-title":"The Tourette syndrome diagnostic confidence index: development and clinical associations","volume":"53","author":"Robertson","year":"1999","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/archdischild-2011-300585","article-title":"The Gilles de la Tourette syndrome: the current status","volume":"97","author":"Robertson","year":"2012","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"key20160120090146612_ref1-bib10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jpsychores.2008.03.006","article-title":"The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 1: The epidemiological and prevalence studies","volume":"65","author":"Robertson","year":"2008","journal-title":"J Psychosom Res"},{"key":"key20160120090146612_ref1-bib11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jpsychores.2008.03.007","article-title":"The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: Tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes","volume":"65","author":"Robertson","year":"2008","journal-title":"J Psychosom Res"},{"key":"key20160120090146612_ref1-bib12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2012.05.002","article-title":"Prevalence of tic disorders: a systematic review and meta-analysis","volume":"47","author":"Knight","year":"2012","journal-title":"Pediatr Neurol"},{"key":"key20160120090146612_ref1-bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/med\/9780199796267.003.0003","volume-title":"Tourette Syndrome","author":"Ferrao","year":"2013"},{"key":"key20160120090146612_ref1-bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/med\/9780199796267.003.0004","volume-title":"Tourette Syndrome","author":"Cath","year":"2013"},{"key":"key20160120090146612_ref1-bib15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1469-8749.2003.tb00402.x","article-title":"Prevalence of tic disorders and Tourette syndrome in a Swedish school population","volume":"45","author":"Khalifa","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"key20160120090146612_ref1-bib16","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1111\/j.1651-2227.2005.tb01837.x","article-title":"Tourette syndrome and other tic disorders in a total population of children: clinical assessment and background","volume":"94","author":"Khalifa","year":"2005","journal-title":"Acta Paediatr"},{"key":"key20160120090146612_ref1-bib17","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1177\/0883073808316370","article-title":"Validation of the presence of comorbidities in a Danish clinical cohort of children with Tourette syndrome","volume":"23","author":"Mol Debes","year":"2008","journal-title":"J Child Neurol"},{"key":"key20160120090146612_ref1-bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/med\/9780199796267.003.0006","volume-title":"Tourette Syndrome","author":"Scahill","year":"2013"},{"key":"key20160120090146612_ref1-bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/med\/9780199796267.003.0016","volume-title":"Tourette Syndrome","author":"Robertson","year":"2013"},{"key":"key20160120090146612_ref1-bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/med\/9780199796267.003.0007","volume-title":"Tourette Syndrome","author":"Fernandez","year":"2013"},{"key":"key20160120090146612_ref1-bib21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1192\/bjp.164.2.215","article-title":"Evidence against a genetic relationship between Tourette\u2019s syndrome and anxiety, depression, panic and phobic disorders","volume":"164","author":"Pauls","year":"1994","journal-title":"Br J Psychiatry"},{"key":"key20160120090146612_ref1-bib22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1192\/bjp.152.3.383","article-title":"The psychopathology of the Gilles de la Tourette syndrome. A phenomenological analysis","volume":"152","author":"Robertson","year":"1988","journal-title":"Br J Psychiatry"},{"key":"key20160120090146612_ref1-bib23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1155\/1988\/839812","article-title":"Some personality variables in functional neurological disorders","volume":"1","author":"Robertson","year":"1988","journal-title":"Behav Neurol"},{"key":"key20160120090146612_ref1-bib24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1192\/bjp.162.1.114","article-title":"The psychopathology of Gilles de la Tourette\u2019s syndrome. A controlled study","volume":"162","author":"Robertson","year":"1993","journal-title":"Br J Psychiatry"},{"key":"key20160120090146612_ref1-bib25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1192\/bjp.171.3.283","article-title":"Personality disorder and psychopathology in Tourette\u2019s syndrome: a controlled study","volume":"171","author":"Robertson","year":"1997","journal-title":"Br J Psychiatry"},{"key":"key20160120090146612_ref1-bib26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3109\/15622970309167953","article-title":"A controlled study of psychopathology and associated symptoms in Tourette syndrome","volume":"4","author":"Rickards","year":"2003","journal-title":"World J Biol Psychiatry"},{"key":"key20160120090146612_ref1-bib27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1017\/S0021963099005156","article-title":"Social and emotional adjustment in children affected with Gilles de la Tourette\u2019s syndrome: associations with ADHD and family functioning. Attention Deficit Hyperactivity Disorder","volume":"41","author":"Carter","year":"2000","journal-title":"J Child Psychol Psychiatry"},{"key":"key20160120090146612_ref1-bib28","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00787-002-0301-3","article-title":"Obsessive compulsive behaviour and depressive symptoms in young people with Tourette syndrome. A controlled study","volume":"11","author":"Robertson","year":"2002","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib29","first-page":"39","article-title":"Behavioral and affective disorders in Tourette syndrome","volume":"99","author":"Robertson","year":"2006","journal-title":"Adv Neurol"},{"key":"key20160120090146612_ref1-bib30","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00004583-200301000-00016","article-title":"Disruptive behavior in children with Tourette\u2019s syndrome: association with ADHD comorbidity, tic severity, and functional impairment","volume":"42","author":"Sukhodolsky","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.braindev.2006.12.003","article-title":"Disentangling the effects of Tourette syndrome and attention deficit hyperactivity disorder on cognitive and behavioral phenotypes","volume":"29","author":"Rizzo","year":"2007","journal-title":"Brain Dev"},{"key":"key20160120090146612_ref1-bib32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1600-0447.2009.01398.x","article-title":"Adults with Tourette\u2019s syndrome with and without attention deficit hyperactivity disorder","volume":"120","author":"Haddad","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"key20160120090146612_ref1-bib33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1034\/j.1600-0447.2001.00147.x","article-title":"Quality of Life (QOL) of patients with Gilles de la Tourette\u2019s syndrome","volume":"103","author":"Elstner","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"key20160120090146612_ref1-bib34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pediatrneurol.2012.10.006","article-title":"Disease-specific quality of life in young patients with tourette syndrome","volume":"48","author":"Cavanna","year":"2013","journal-title":"Pediatr Neurol"},{"key":"key20160120090146612_ref1-bib35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1176\/appi.neuropsych.11080181","article-title":"The effects of comorbid obsessive\u2013compulsive disorder and attention-deficit hyperactivity disorder on quality of life in tourette syndrome","volume":"24","author":"Eddy","year":"2012","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"key20160120090146612_ref1-bib36","first-page":"171","volume-title":"A Family Guide to Tourette Syndrome","author":"Robertson","year":"2012"},{"key":"key20160120090146612_ref1-bib37","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/med\/9780199796267.003.0021","volume-title":"Tourette Syndrome","author":"Sukhodolsky","year":"2013"},{"key":"key20160120090146612_ref1-bib38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1017\/S0021963098002480","article-title":"Peer relationship problems in children with\u2009Tourette\u2019s disorder or diabetes mellitus","volume":"39","author":"Bawden","year":"1998","journal-title":"J Child Psychol Psychiatry"},{"key":"key20160120090146612_ref1-bib39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/01.JNR.0000387612.85897.9a","article-title":"Parenting stress and related factors in parents of children with Tourette syndrome","volume":"15","author":"Lee","year":"2007","journal-title":"J Nurs Res"},{"key":"key20160120090146612_ref1-bib40","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1097\/01.CHI.0000085751.71002.48","article-title":"Psychological morbidity and caregiver burden in parents of children with Tourette\u2019s disorder and psychiatric comorbidity","volume":"42","author":"Cooper","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib41","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1385\/1-59259-326-7:443","volume-title":"Mental and Behavioral Dysfunction in Movement Disorders","author":"Robertson","year":"2003"},{"key":"key20160120090146612_ref1-bib42","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.biopsych.2008.01.019","article-title":"Tourette Syndrome Association International Consortium for Genetics; Latent class analysis of Gilles de la Tourette syndrome using comorbidities: clinical and genetic implications","volume":"64","author":"Grados","year":"2008","journal-title":"Biol Psychiatry"},{"key":"key20160120090146612_ref1-bib43","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1136\/jnnp.2010.225029","article-title":"Dissecting the Gilles de la Tourette spectrum: a factor analytic study on 639 patients","volume":"82","author":"Cavanna","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20160120090146612_ref1-bib44","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/ene.12274","article-title":"Sex-related and non sex-related comorbidity subtypes of tic disorders: a latent class approach","volume":"21","author":"Rodgers","year":"2014","journal-title":"Eur J Neurol"},{"key":"key20160120090146612_ref1-bib45","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/brain\/123.3.425","article-title":"Tourette syndrome, associated conditions and the complexities of treatment","volume":"123","author":"Robertson","year":"2000","journal-title":"Brain"},{"key":"key20160120090146612_ref1-bib46","doi-asserted-by":"publisher","first-page":"100","DOI":"10.12968\/hmed.2011.72.2.100","article-title":"Gilles de la Tourette syndrome: the complexities of phenotype and treatment","volume":"72","author":"Robertson","year":"2011","journal-title":"Br J Hosp Med"},{"key":"key20160120090146612_ref1-bib47","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/ana.410220317","article-title":"The natural history of Tourette syndrome: a follow-up study","volume":"22","author":"Erenberg","year":"1987","journal-title":"Ann Neurol"},{"key":"key20160120090146612_ref1-bib48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1542\/peds.102.1.14","article-title":"Course of tic severity in Tourette syndrome: the first two decades","volume":"102","author":"Leckman","year":"1998","journal-title":"Pediatrics"},{"key":"key20160120090146612_ref1-bib49","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/01.nmd.0000144696.14555.c4","article-title":"Reexamining tic persistence and tic-associated impairment in Tourette\u2019s Disorder findings from a naturalistic follow-up study","volume":"192","author":"Coffey","year":"2004","journal-title":"J Nerv Ment Dis"},{"key":"key20160120090146612_ref1-bib50","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1469-7610.2005.01561.x","article-title":"Fine-motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette\u2019s syndrome","volume":"47","author":"Bloch","year":"2006","journal-title":"J Child Psychol Psychiatry"},{"key":"key20160120090146612_ref1-bib51","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1212\/01.WNL.0000086370.10186.7C","article-title":"Objective assessments of longitudinal outcome in Gilles de la Tourette\u2019s syndrome","volume":"61","author":"Pappert","year":"2003","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1469-7610.2006.01687.x","article-title":"Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and\/or obsessive\u2013compulsive disorder","volume":"48","author":"Lin","year":"2007","journal-title":"J Child Psychol Psychiatry"},{"key":"key20160120090146612_ref1-bib53","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.braindev.2011.11.006","article-title":"Long term clinical course of Tourette syndrome","volume":"34","author":"Rizzo","year":"2012","journal-title":"Brain Dev"},{"key":"key20160120090146612_ref1-bib54","first-page":"1","article-title":"Psychoanalytic observations on tic","volume":"2","author":"Ferenczi","year":"1921","journal-title":"Int J Psychoanal"},{"key":"key20160120090146612_ref1-bib55","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/BF01561841","article-title":"A psychosomatic study of maladie des tics (Gilles de la Tourette\u2019s Disease)","volume":"17","author":"Mahler","year":"1943","journal-title":"Psychiatr Q"},{"key":"key20160120090146612_ref1-bib56","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1086\/302613","article-title":"A complete genome scan in sib-pairs affected with Gilles de la Tourette Syndrome","volume":"65","author":"The Tourette Syndrome Association International Consortium for Genetics","year":"1999","journal-title":"Am J Hum Gen"},{"key":"key20160120090146612_ref1-bib57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jaac.2011.11.004","article-title":"Prevalence of Tourette syndrome and chronic tics in the population-based Avon longitudinal study of parents and children cohort","volume":"51","author":"Scharf","year":"2012","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib58","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/mp.2012.69","article-title":"Genome-wide association study of Tourette\u2019s syndrome","volume":"18","author":"Scharf","year":"2014","journal-title":"Mol Psychiatry"},{"key":"key20160120090146612_ref1-bib59","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1126\/science.1116502","article-title":"Sequence variants in SLITRK1 are associated with Tourette\u2019s syndrome","volume":"310","author":"Abelson","year":"2005","journal-title":"Science"},{"key":"key20160120090146612_ref1-bib60","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1212\/01.wnl.0000296833.25484.bb","article-title":"Lack of association between SLITRK1var321 and Tourette syndrome in a large family-based sample","volume":"70","author":"Scharf","year":"2008","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib61","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa0907006","article-title":"L-Histidine decarboxylase and Tourette\u2019s syndrome","volume":"362","author":"Ercan-Sencicek","year":"2010","journal-title":"N Engl J Med"},{"key":"key20160120090146612_ref1-bib62","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ajp.155.2.264","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases","volume":"155","author":"Swedo","year":"1998","journal-title":"Am J Psychiatry"},{"key":"key20160120090146612_ref1-bib63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0006-3223(03)00704-2","article-title":"Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive\u2013compulsive disorder and tics","volume":"55","author":"Murphy","year":"2004","journal-title":"Biol Psychiatry"},{"key":"key20160120090146612_ref1-bib64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1542\/peds.92.1.39","article-title":"Antineuronal antibodies in movement disorders","volume":"92","author":"Kiessling","year":"1993","journal-title":"Pediatrics"},{"key":"key20160120090146612_ref1-bib65","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00004703-199412000-00005","article-title":"Antineuronal antibodies: tics and obsessive\u2013compulsive symptoms","volume":"15","author":"Kiessling","year":"1994","journal-title":"J Dev Behav Pediatr"},{"key":"key20160120090146612_ref1-bib66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0165-1781(00)00125-6","article-title":"Increased anti-streptococcal antibodies in patients with Tourette\u2019s syndrome","volume":"94","author":"Muller","year":"2000","journal-title":"Psychiatry Res"},{"key":"key20160120090146612_ref1-bib67","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0165-1781(01)00215-3","article-title":"Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette\u2019s syndrome","volume":"101","author":"Muller","year":"2001","journal-title":"Psychiatry Res"},{"key":"key20160120090146612_ref1-bib68","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1136\/jnnp.74.5.602","article-title":"Tourette\u2019s syndrome: a cross sectional study to examine the PANDAS hypothesis","volume":"74","author":"Church","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20160120090146612_ref1-bib69","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1177\/08830738060210091001","article-title":"Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: Controlled cross-sectional study","volume":"21","author":"Rizzo","year":"2006","journal-title":"J Child Neurol"},{"key":"key20160120090146612_ref1-bib70","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1001\/archpsyc.57.4.364","article-title":"Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive\u2013compulsive, and attention deficit\/hyperactivity disorders","volume":"57","author":"Peterson","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"key20160120090146612_ref1-bib71","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1542\/peds.2007-2658","article-title":"Serial immune markers do not correlate with clinical exacerbations in pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections","volume":"121","author":"Singer","year":"2008","journal-title":"Pediatrics"},{"key":"key20160120090146612_ref1-bib72","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/med\/9780199796267.003.0009","volume-title":"Tourette Syndrome","author":"Murphy","year":"2013"},{"key":"key20160120090146612_ref1-bib73","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2147\/IJGM.S24212","article-title":"Lyme disease and pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an overview","volume":"5","author":"Rhee","year":"2012","journal-title":"Int J Gen Med"},{"key":"key20160120090146612_ref1-bib74","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/S0140-6736(05)78357-4","article-title":"Lyme disease presenting as Tourette\u2019s syndrome","volume":"351","author":"Riedel","year":"1998","journal-title":"Lancet"},{"key":"key20160120090146612_ref1-bib75","author":"Court","year":"2013","journal-title":"One Bite Changed My Life Forever"},{"key":"key20160120090146612_ref1-bib76","first-page":"20","volume-title":"Yours Magazine","author":"Editorial","year":"2013"},{"key":"key20160120090146612_ref1-bib77","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1385\/1-59259-326-7:467","volume-title":"Mental and Behavioral Dysfunction in Movement Disorders","author":"Leckman","year":"2003"},{"key":"key20160120090146612_ref1-bib78","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0022-3476(56)80095-4","article-title":"A study of the association of prenatal and paranatal factors with the development of tics in children; a preliminary investigation","volume":"48","author":"Pasamanick","year":"1956","journal-title":"J Pediatr"},{"key":"key20160120090146612_ref1-bib79","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1515\/jpm.1999.042","article-title":"Prenatal and perinatal risk factors for Tourette disorder","volume":"27","author":"Burd","year":"1999","journal-title":"J Perinat Med"},{"key":"key20160120090146612_ref1-bib80","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1176\/ajp.2006.163.6.1066","article-title":"Association between maternal smoking and increased symptom severity in Tourette\u2019s syndrome","volume":"163","author":"Mathews","year":"2006","journal-title":"Am J Psychiatry"},{"key":"key20160120090146612_ref1-bib81","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/med\/9780199796267.003.0008","volume-title":"Tourette Syndrome","author":"Hoekstra","year":"2013"},{"key":"key20160120090146612_ref1-bib82","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/med\/9780199796267.003.0020","volume-title":"Tourette Syndrome","author":"Murphy","year":"2013"},{"key":"key20160120090146612_ref1-bib83","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cub.2006.01.064","article-title":"Enhanced cognitive control in young people with Tourette\u2019s syndrome","volume":"16","author":"Mueller","year":"2006","journal-title":"Curr Biol"},{"key":"key20160120090146612_ref1-bib84","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cub.2011.02.047","article-title":"Compensatory neural reorganization in Tourette syndrome","volume":"21","author":"Jackson","year":"2011","journal-title":"Curr Biol"},{"key":"key20160120090146612_ref1-bib85","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/med\/9780199796267.003.0012","volume-title":"Tourette Syndrome","author":"Greene","year":"2013"},{"key":"key20160120090146612_ref1-bib86","volume-title":"Tourette\u2019s with Dignity. Don\u2019t Tic Me Off. The Youthdale Series","author":"Sandor","year":"2013"},{"key":"key20160120090146612_ref1-bib87","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00415-010-5754-6","article-title":"Quality of life in young people with Tourette syndrome: a controlled study","volume":"258","author":"Eddy","year":"2011","journal-title":"J Neurol"},{"key":"key20160120090146612_ref1-bib88","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/15374410701279545","article-title":"Quality of life in youth with Tourette\u2019s syndrome and chronic tic disorder","volume":"36","author":"Storch","year":"2007","journal-title":"J Clin Child Adolesc Psychol"},{"key":"key20160120090146612_ref1-bib89","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1177\/002221949202500909","article-title":"Tourette Syndrome and learning-disabilities","volume":"25","author":"Burd","year":"1992","journal-title":"J Learn Disabil"},{"key":"key20160120090146612_ref1-bib90","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"Higgins","year":"2011"},{"key":"key20160120090146612_ref1-bib91","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"key20160120090146612_ref1-bib92","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1192\/bjp.114.508.345","article-title":"Treatment of Gilles de la Tourette\u2019s Syndrome with haloperidol","volume":"114","author":"Shapiro","year":"1968","journal-title":"Br J Psychiatry"},{"key":"key20160120090146612_ref1-bib93","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1177\/08830738060210080901","article-title":"Tic disorders: neural circuits, neurochemistry, and neuroimmunology","volume":"21","author":"Harris","year":"2006","journal-title":"J Child Neurol"},{"key":"key20160120090146612_ref1-bib94","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00787-011-0163-7","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment","volume":"20","author":"Roessner","year":"2011","journal-title":"Eur Child Adolesc Psych"},{"key":"key20160120090146612_ref1-bib95","doi-asserted-by":"publisher","first-page":"CD007990","DOI":"10.1002\/14651858.cd007990.pub2","article-title":"Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders","volume":"4","author":"Pringsheim","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"key20160120090146612_ref1-bib96","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1155\/2013\/626410","article-title":"Trials of pharmacological interventions for Tourette syndrome: a systematic review","volume":"26","author":"Waldon","year":"2013","journal-title":"Behav Neurol"},{"key":"key20160120090146612_ref1-bib97","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.neuropharm.2012.05.043","article-title":"Pharmacological treatment of tic disorders and Tourette Syndrome","volume":"68","author":"Roessner","year":"2013","journal-title":"Neuropharmacology"},{"key":"key20160120090146612_ref1-bib98","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1176\/ajp.154.8.1057","article-title":"Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette\u2019s disorder","volume":"154","author":"Sallee","year":"1997","journal-title":"Am J Psychiatry"},{"key":"key20160120090146612_ref1-bib99","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/archpsyc.1989.01810080052006","article-title":"Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette\u2019s syndrome","volume":"46","author":"Shapiro","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"key20160120090146612_ref1-bib100","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/00004583-198403000-00007","article-title":"Controlled study of pimozide vs. placebo in Tourette\u2019s syndrome","volume":"23","author":"Shapiro","year":"1984","journal-title":"J Am Acad Child Psychiatry"},{"key":"key20160120090146612_ref1-bib101","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1212\/01.WNL.0000055434.39968.67","article-title":"A placebo-controlled trial of risperidone in Tourette syndrome","volume":"60","author":"Scahill","year":"2003","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib102","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00004714-200202000-00006","article-title":"Risperidone in the treatment of Tourette syndrome: A double-blind, placebo-controlled trial","volume":"22","author":"Dion","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"key20160120090146612_ref1-bib103","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/00004583-200003000-00010","article-title":"Ziprasidone treatment of children and adolescents with Tourette\u2019s syndrome: A pilot study","volume":"39","author":"Sallee","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib104","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/00004583-200402000-00017","article-title":"Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial","volume":"43","author":"Gilbert","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib105","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4088\/JCP.v62n0111","article-title":"Risperidone versus pimozide in Tourette\u2019s disorder: A comparative double-blind parallel-group study","volume":"62","author":"Bruggeman","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"key20160120090146612_ref1-bib106","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1176\/ajp.135.5.585","article-title":"A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette\u2019s syndrome","volume":"135","author":"Ross","year":"1978","journal-title":"Am J Psychiatry"},{"key":"key20160120090146612_ref1-bib107","first-page":"572","article-title":"A multicenter controlled study on aripiprazole treatment for children with Tourette syndrome in China","volume":"49","author":"Liu","year":"2011","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"key20160120090146612_ref1-bib108","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00787-010-0154-0","article-title":"Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders","volume":"20","author":"Yoo","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib109","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s10072-011-0678-1","article-title":"Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome","volume":"32","author":"Gulisano","year":"2011","journal-title":"Neurol Sci"},{"key":"key20160120090146612_ref1-bib110","first-page":"66","article-title":"Olanzapine for treatment of Tourette syndrome: a double-blind randomised controlled trial","volume":"9","author":"Ji","year":"2005","journal-title":"Chin J Clin Rehabil"},{"key":"key20160120090146612_ref1-bib111","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1176\/ajp.144.5.673","article-title":"ECG changes during haloperidol and pimozide treatment of Tourette\u2019s disorder","volume":"144","author":"Fulop","year":"1987","journal-title":"Am J Psychiatry"},{"key":"key20160120090146612_ref1-bib112","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00004714-200006000-00005","article-title":"Studies on the mechanism of a fatal clarithromycin\u2013pimozide interaction in a patient with Tourette syndrome","volume":"20","author":"Flockhart","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"key20160120090146612_ref1-bib113","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1212\/WNL.58.4.527","article-title":"Treatment of ADHD in children with tics: A randomized controlled trial","volume":"58","author":"Kurlan","year":"2002","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib114","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ana.410210313","article-title":"Clonidine and Gilles de la Tourette\u2019s syndrome: double-blind study using objective rating methods","volume":"21","author":"Goetz","year":"1987","journal-title":"Ann Neurol"},{"key":"key20160120090146612_ref1-bib115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/peds.95.1.74","article-title":"The treatment of attention-deficit hyperactivity disorder in Tourette\u2019s syndrome: a double-blind placebo-controlled study with clonidine and desipramine","volume":"95","author":"Singer","year":"1995","journal-title":"Pediatrics"},{"key":"key20160120090146612_ref1-bib116","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1001\/archpsyc.1991.01810280040006","article-title":"Clonidine treatment of Gilles de la Tourette\u2019s syndrome","volume":"48","author":"Leckman","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"key20160120090146612_ref1-bib117","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/00048670802277222","article-title":"Randomized double-blind multicentre placebo-controlled clinical trial of the clonidine adhesive patch for the treatment of tic disorders","volume":"42","author":"Du","year":"2008","journal-title":"Aust N Z J Psychiatry"},{"key":"key20160120090146612_ref1-bib118","first-page":"785","article-title":"Randomized double-blind controlled study on treatment of tic disorders in children with transcutaneous patch of clonidine","volume":"45","author":"Zhong","year":"2007","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"key20160120090146612_ref1-bib119","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1176\/jnp.2.1.66","article-title":"Treatment of Tourette\u2019s syndrome with transdermal clonidine: a pilot study","volume":"2","author":"Gancher","year":"1990","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"key20160120090146612_ref1-bib120","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","article-title":"A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder","volume":"158","author":"Scahill","year":"2001","journal-title":"Am J Psychiatry"},{"key":"key20160120090146612_ref1-bib121","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00002826-200211000-00009","article-title":"Neuropsychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study","volume":"25","author":"Cummings","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"key20160120090146612_ref1-bib122","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1212\/01.wnl.0000188869.58300.a7","article-title":"Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders","volume":"65","author":"Allen","year":"2005","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib123","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/1087054707306109","article-title":"Atomoxetine treatment of ADHD in children with comorbid tourette syndrome","volume":"11","author":"Spencer","year":"2008","journal-title":"J Atten Disord"},{"key":"key20160120090146612_ref1-bib124","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/00004583-199205000-00012","article-title":"Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings","volume":"31","author":"Gadow","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib125","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/chi.0b013e31805c0860","article-title":"Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder","volume":"46","author":"Gadow","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib126","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/00004583-199705000-00008","article-title":"Controlled stimulant treatment of ADHD and comorbid Tourette\u2019s syndrome: Effects of stimulant and dose","volume":"36","author":"Castellanos","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib127","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/cap.2010.0032","article-title":"Testing tic suppression: Comparing the effects of dexmethylphenidate to no medication in children and adolescents with attention-deficit\/hyperactivity disorder and Tourette\u2019s disorder","volume":"20","author":"Lyon","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"key20160120090146612_ref1-bib128","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1212\/01.wnl.0000200779.03748.0f","article-title":"Topiramate in essential tremor: a double-blind, placebo-controlled trial","volume":"66","author":"Ondo","year":"2006","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib129","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1002\/mds.21615","article-title":"A double blind randomized placebo control trial of levetiracetam in Tourette syndrome","volume":"22","author":"Smith-Hicks","year":"2007","journal-title":"Mov Disord"},{"key":"key20160120090146612_ref1-bib130","first-page":"257","article-title":"Levetiracetam in Tourette syndrome: a randomized double blind, placebo controlled study","volume":"7","author":"Awaad","year":"2009","journal-title":"J Pediatr Neurol"},{"key":"key20160120090146612_ref1-bib131","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/jnnp.2009.185348","article-title":"A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome","volume":"81","author":"Jankovic","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20160120090146612_ref1-bib132","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1212\/WNL.46.4.965","article-title":"A controlled trial of deprenyl in children with Tourette\u2019s syndrome and attention deficit hyperactivity disorder","volume":"46","author":"Feigin","year":"1996","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib133","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1056\/NEJMoa054830","article-title":"Valvular heart disease and the use of dopamine agonists for Parkinson\u2019s disease","volume":"356","author":"Zanettini","year":"2007","journal-title":"N Engl J Med"},{"key":"key20160120090146612_ref1-bib134","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1056\/NEJMoa062222","article-title":"Dopamine agonists and the risk of cardiac-valve regurgitation","volume":"356","author":"Schade","year":"2007","journal-title":"N Engl J Med"},{"key":"key20160120090146612_ref1-bib135","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1212\/WNL.54.6.1310","article-title":"Tourette\u2019s syndrome improvement with pergolide in a randomized, double-blind, crossover trial","volume":"54","author":"Gilbert","year":"2000","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib136","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1212\/01.WNL.0000044058.64647.7E","article-title":"Tic reduction with pergolide in a randomized controlled trial in children","volume":"60","author":"Gilbert","year":"2003","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib137","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/mds.24919","article-title":"A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette\u2019s syndrome","volume":"27","author":"Kurlan","year":"2012","journal-title":"Mov Disord"},{"key":"key20160120090146612_ref1-bib138","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/01.chi.0000163279.39598.44","article-title":"A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette\u2019s disorder","volume":"44","author":"Nicolson","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib139","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4088\/JCP.v66n0413","article-title":"Ondansetron treatment in Tourette\u2019s disorder: a 3-week, randomized, double-blind, placebo-controlled study","volume":"66","author":"Toren","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"key20160120090146612_ref1-bib140","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1212\/WNL.56.5.599","article-title":"Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial","volume":"56","author":"Singer","year":"2001","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib141","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/archpsyc.59.7.649","article-title":"A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit\/hyperactivity disorder","volume":"59","author":"Spencer","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"key20160120090146612_ref1-bib142","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejpn.2011.12.001","article-title":"Treatment practices in Tourette syndrome: the European perspective","volume":"16","author":"Rickards","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"key":"key20160120090146612_ref1-bib143","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00002826-199304000-00009","article-title":"A pilot controlled study of fluoxetine for obsessive\u2013compulsive symptoms in children with Tourette\u2019s syndrome","volume":"16","author":"Kurlan","year":"1993","journal-title":"Clin Neuropharmacol"},{"key":"key20160120090146612_ref1-bib144","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/cap.1997.7.75","article-title":"Fluoxetine has no marked effect on tic symptoms in patients with Tourette\u2019s syndrome: a double-blind placebo-controlled study","volume":"7","author":"Scahill","year":"1997","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"key20160120090146612_ref1-bib145","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0140-6736(05)60822-7","article-title":"Treatment of Tourette\u2019s syndrome with mecamylamine","volume":"352","author":"Sanberg","year":"1998","journal-title":"Lancet"},{"key":"key20160120090146612_ref1-bib146","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1097\/00004583-200109000-00020","article-title":"Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for tourette\u2019s disorder","volume":"40","author":"Silver","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib147","doi-asserted-by":"publisher","first-page":"707","DOI":"10.4088\/JCP.v62n0908","article-title":"Transdermal nicotine and haloperidol in Tourette\u2019s disorder: a double-blind placebo-controlled study","volume":"62","author":"Silver","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"key20160120090146612_ref1-bib148","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.eurpsy.2003.11.002","article-title":"Clinical and attentional effects of acute nicotine treatment in Tourette\u2019s syndrome","volume":"19","author":"Howson","year":"2004","journal-title":"Eur Psychiatry"},{"key":"key20160120090146612_ref1-bib149","doi-asserted-by":"publisher","first-page":"e1493","DOI":"10.1542\/peds.2011-3384","article-title":"A double-blind, placebo-controlled trial of omega-3 fatty acids in Tourette\u2019s disorder","volume":"129","author":"Gabbay","year":"2012","journal-title":"Pediatrics"},{"key":"key20160120090146612_ref1-bib150","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/00004583-200203000-00013","article-title":"Risperidone versus clonidine in the treatment of children and adolescents with Tourette\u2019s syndrome","volume":"41","author":"Gaffney","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib151","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/hup.470080505","article-title":"Fluvoxamine and sulpiride in comorbid obsessive\u2013compulsive disorder and Gilles de la Tourette Syndrome","volume":"8","author":"George","year":"1993","journal-title":"Hum Psychopharmacol"},{"key":"key20160120090146612_ref1-bib152","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.pediatrneurol.2008.12.014","article-title":"Double-Blind, Crossover Study of Clonidine and Levetiracetam in Tourette Syndrome","volume":"40","author":"Hedderick","year":"2009","journal-title":"Pediatric Neurology"},{"key":"key20160120090146612_ref1-bib153","first-page":"537","article-title":"Efficacy of clonidine transdermal patch for treatment of Tourette\u2019s syndrome in children","volume":"11","author":"Kang","year":"2009","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"key20160120090146612_ref1-bib154","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0005-7967(73)90119-8","article-title":"Habit-reversal: a method of eliminating nervous habits and tics","volume":"11","author":"Azrin","year":"1973","journal-title":"Behav Res Ther"},{"key":"key20160120090146612_ref1-bib155","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/0005-7967(94)00066-S","article-title":"Competing responses for the treatment of Tourette syndrome and tic disorders","volume":"33","author":"Carr","year":"1995","journal-title":"Behav Res Ther"},{"key":"key20160120090146612_ref1-bib156","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1001\/jama.2010.607","article-title":"Behavior therapy for children with tourette disorder: A randomized controlled trial","volume":"303","author":"Piacentini","year":"2010","journal-title":"JAMA"},{"key":"key20160120090146612_ref1-bib157","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/jnnp-2012-303033","article-title":"Are premonitory urges a prerequisite of tic inhibition in Gilles de la Tourette syndrome?","volume":"83","author":"Ganos","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key20160120090146612_ref1-bib158","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00787-011-0167-3","article-title":"European clinical guidelines for Tourette Syndrome and other tic disorders. Part III: behavioural and psychosocial interventions","volume":"20","author":"Verdellen","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib159","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/070674371205700303","article-title":"Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation","volume":"57","author":"Steeves","year":"2012","journal-title":"Can J Psychiatry"},{"key":"key20160120090146612_ref1-bib160","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/(SICI)1099-0879(199706)4:2<125::AID-CPP125>3.0.CO;2-Z","article-title":"Exposure and response prevention in the treatment of Gilles de la Tourette\u2019s Syndrome: four case studies","volume":"4","author":"Hoogduim","year":"1998","journal-title":"Clin Psychol Psychother"},{"key":"key20160120090146612_ref1-bib161","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1037\/h0040699","article-title":"The application of learning theory to the treatment of tics","volume":"56","author":"Yates","year":"1958","journal-title":"J Abnorm Soc Psychol"},{"key":"key20160120090146612_ref1-bib162","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0005-7967(92)90140-C","article-title":"An evaluation of behavioral treatments for Tourette syndrome","volume":"30","author":"Peterson","year":"1992","journal-title":"Behav Res Ther"},{"key":"key20160120090146612_ref1-bib163","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.avb.2003.08.005","article-title":"Cognitive-behavioral therapy for anger in children and adolescents: a meta-analysis","volume":"9","author":"Sukhodolsky","year":"2004","journal-title":"Aggress Violent Beh"},{"key":"key20160120090146612_ref1-bib164","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/08830738060210080201","article-title":"Randomized trial of parent management training in children with tic disorders and disruptive behavior","volume":"21","author":"Scahill","year":"2006","journal-title":"J Child Neurol"},{"key":"key20160120090146612_ref1-bib165","first-page":"36","article-title":"Psychosocial treatments for attention-deficit\/hyperactivity disorder in children","volume":"63","author":"Barkley","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"key20160120090146612_ref1-bib166","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1001\/archgenpsychiatry.2011.1528","article-title":"Randomized trial of behavior therapy for adults with Tourette syndrome","volume":"69","author":"Wilhelm","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"key20160120090146612_ref1-bib167","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1176\/appi.ajp.160.6.1175","article-title":"Habit reversal versus supportive psychotherapy for Tourette\u2019s disorder: a randomized controlled trial","volume":"160","author":"Wilhelm","year":"2003","journal-title":"Am J Psychiatry"},{"key":"key20160120090146612_ref1-bib168","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.brat.2005.08.007","article-title":"Habit reversal versus supportive psychotherapy in Tourette\u2019s disorder: A randomized controlled trial and predictors of treatment response","volume":"44","author":"Deckersbach","year":"2006","journal-title":"Behav Res Ther"},{"key":"key20160120090146612_ref1-bib169","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0005-7894(05)80333-8","article-title":"Treatment of Tourette Syndrome by habit reversal: a waiting-list control group comparison","volume":"21","author":"Azrin","year":"1990","journal-title":"Behav Ther"},{"key":"key20160120090146612_ref1-bib170","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0005-7894(80)80017-7","article-title":"Habit reversal vs negative practice treatment of nervous tics","volume":"11","author":"Azrin","year":"1980","journal-title":"Behav Ther"},{"key":"key20160120090146612_ref1-bib171","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0005-7967(03)00154-2","article-title":"Exposure with response prevention versus habit reversal in Tourette\u2019s syndrome: A controlled study","volume":"42","author":"Verdellen","year":"2004","journal-title":"Behav Res Ther"},{"key":"key20160120090146612_ref1-bib172","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.brat.2012.05.009","article-title":"A randomized pilot trial comparing videoconference versus face-to-face delivery of behavior therapy for childhood tic disorders","volume":"50","author":"Himle","year":"2012","journal-title":"Behav Res Ther"},{"key":"key20160120090146612_ref1-bib173","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S0887-8994(97)00200-2","article-title":"Relaxation therapy in Tourette syndrome: a pilot study","volume":"18","author":"Bergin","year":"1998","journal-title":"Pediatr Neurol"},{"key":"key20160120090146612_ref1-bib174","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/CHI.0b013e3181985050","article-title":"Randomized trial of anger control training for adolescents with Tourette\u2019s syndrome and disruptive behavior","volume":"48","author":"Sukhodolsky","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib175","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1177\/0883073810397046","article-title":"Behavior therapy for tics in children: acute and long-term effects on psychiatric and psychosocial functioning","volume":"26","author":"Woods","year":"2011","journal-title":"J Child Neurol"},{"key":"key20160120090146612_ref1-bib176","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ncpneuro0193","article-title":"Surgery insight: Deep brain stimulation for movement disorders. Nature clinical practice","volume":"2","author":"Anderson","year":"2006","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib177","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3109\/02688697.2010.534200","article-title":"An approach to deep brain stimulation for severe treatment-refractory Tourette syndrome: the UK perspective","volume":"25","author":"Cavanna","year":"2011","journal-title":"Br J Neurosurg"},{"key":"key20160120090146612_ref1-bib178","doi-asserted-by":"publisher","first-page":"662","DOI":"10.4065\/mcp.2011.0045","article-title":"Deep brain stimulation: current and future clinical applications","volume":"86","author":"Lyons","year":"2011","journal-title":"Mayo Clinic Proc"},{"key":"key20160120090146612_ref1-bib179","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/S0140-6736(98)05964-9","article-title":"Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus","volume":"353","author":"Vandewalle","year":"1999","journal-title":"Lancet"},{"key":"key20160120090146612_ref1-bib180","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1227\/NEU.0b013e3182535a00","article-title":"What patients with Gilles de la tourette syndrome should be treated with deep brain stimulation and what is the best target?","volume":"71","author":"Piedad","year":"2012","journal-title":"Neurosurgery"},{"key":"key20160120090146612_ref1-bib181","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1460-9568.2010.07415.x","article-title":"Gilles de la Tourette syndrome and deep brain stimulation","volume":"32","author":"Hariz","year":"2010","journal-title":"Eur J Neurosci"},{"key":"key20160120090146612_ref1-bib182","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/mds.21039","article-title":"Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome","volume":"21","author":"Mink","year":"2006","journal-title":"Mov Disord"},{"key":"key20160120090146612_ref1-bib183","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00787-011-0166-4","article-title":"European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation","volume":"20","author":"Muller-Vahl","year":"2011","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib184","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S1474-4422(08)70190-X","article-title":"Clinical applications of transcranial magnetic stimulation in patients with movement disorders","volume":"7","author":"Edwards","year":"2008","journal-title":"Lancet Neurol"},{"key":"key20160120090146612_ref1-bib185","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.clinph.2003.10.037","article-title":"Should transcranial magnetic stimulation research in children be considered minimal risk?","volume":"115","author":"Gilbert","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"key20160120090146612_ref1-bib186","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.mp.4000972","article-title":"Is Tourette\u2019s syndrome an autoimmune disease?","volume":"7","author":"Hoekstra","year":"2002","journal-title":"Mol Psychiatry"},{"key":"key20160120090146612_ref1-bib187","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4088\/JCP.v65n0413","article-title":"Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study","volume":"65","author":"Hoekstra","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"key20160120090146612_ref1-bib188","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s12016-009-8155-9","article-title":"Evidence for the use of intravenous immunoglobulins \u2013 a review of the literature","volume":"38","author":"Kivity","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"key20160120090146612_ref1-bib189","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/FAD.0b013e328346f575","article-title":"Botulinum toxins: Adverse effects","author":"Anton","journal-title":"Adverse Drug React Bull"},{"key":"key20160120090146612_ref1-bib190","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11920-008-0052-z","article-title":"Emerging treatment for Tourette\u2019s disorder","volume":"10","author":"Bloch","year":"2008","journal-title":"Curr Psychiatry Rep"},{"key":"key20160120090146612_ref1-bib191","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/BF02083302","article-title":"Guidelines for the therapeutic use of botulinum toxin in movement disorders. Italian Study Group for Movement Disorders","volume":"18","author":"Berardelli","year":"1997","journal-title":"Ital Soc Neurol"},{"key":"key20160120090146612_ref1-bib192","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1212\/01.wnl.0000311389.26145.95","article-title":"Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib193","doi-asserted-by":"publisher","first-page":"CD007832","DOI":"10.1002\/14651858.cd007832","article-title":"Acupuncture for Gilles de la Tourette\u2019s syndrome","author":"Cui","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"key20160120090146612_ref1-bib194","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/brain\/awq380","article-title":"Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome","volume":"134","author":"Ackermans","year":"2011","journal-title":"Brain"},{"key":"key20160120090146612_ref1-bib195","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1001\/archneur.65.7.952","article-title":"Internal pallidal and thalamic stimulation in patients with Tourette syndrome","volume":"65","author":"Welter","year":"2008","journal-title":"Arch Neurol"},{"key":"key20160120090146612_ref1-bib196","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3171\/JNS-07\/11\/1004","article-title":"Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome","volume":"107","author":"Maciunas","year":"2007","journal-title":"J Neurosurg"},{"key":"key20160120090146612_ref1-bib197","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.clinph.2004.10.003","article-title":"Subthreshold rTMS over pre-motor cortex has no effect on tics in patients with Gilles de la Tourette syndrome","volume":"116","author":"Orth","year":"2005","journal-title":"Clin Neurophysiol"},{"key":"key20160120090146612_ref1-bib198","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/01.wnn.0000116253.78804.3a","article-title":"A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette\u2019s syndrome","volume":"17","author":"Chae","year":"2004","journal-title":"Cogn Behav Neurol"},{"key":"key20160120090146612_ref1-bib199","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1212\/01.WNL.0000036615.25044.50","article-title":"Repetitive transcranial magnetic stimulation for Tourette syndrome","volume":"59","author":"Munchau","year":"2002","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib200","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1212\/WNL.56.5.605","article-title":"Botulinum toxin for simple motor tics: A randomized, double-blind, controlled clinical trial","volume":"56","author":"Marras","year":"2001","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib201","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF02845419","article-title":"Clinical study on treatment of tourette\u2019s syndrome with acupuncture-Chinese herbs combination","volume":"1","author":"Chi","year":"2003","journal-title":"Journal of Acupuncture and Tuina Science"},{"key":"key20160120090146612_ref1-bib202","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1212\/WNL.50.6.1530","article-title":"Tourette\u2019s syndrome and \u2018PANDAS\u2019: will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection","volume":"50","author":"Kurlan","year":"1998","journal-title":"Neurology"},{"key":"key20160120090146612_ref1-bib203","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1542\/peds.113.4.883","article-title":"The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive\u2013compulsive symptoms: hypothesis or entity? Practical considerations for the clinician","volume":"113","author":"Kurlan","year":"2004","journal-title":"Pediatrics"},{"key":"key20160120090146612_ref1-bib204","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","article-title":"Therapeutic plasma exchange and intravenous immunoglobulin for obsessive\u2013compulsive disorder and tic disorders in childhood","volume":"354","author":"Perlmutter","year":"1999","journal-title":"Lancet"},{"key":"key20160120090146612_ref1-bib205","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/S0006-3223(99)00020-7","article-title":"A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections","volume":"45","author":"Garvey","year":"1999","journal-title":"Biol Psychiatry"},{"key":"key20160120090146612_ref1-bib206","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.biopsych.2004.12.035","article-title":"Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders","volume":"57","author":"Snider","year":"2005","journal-title":"Biol Psychiatry"},{"key":"key20160120090146612_ref1-bib207","volume-title":"Talking About Medicines (Tabs): Involving Children and Young People With Chronic Illness in Managing Their Medicines. Final Report","author":"Elliott","year":"2013"},{"key":"key20160120090146612_ref1-bib208","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/1359104508100127","article-title":"The diagnosis of Tourette\u2019s Syndrome: communication and impact","volume":"14","author":"Rivera-Navarro","year":"2009","journal-title":"Clin Child Psychol Psychiatry"},{"key":"key20160120090146612_ref1-bib209","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1055\/s-2008-1081457","article-title":"Limited knowledge of Tourette syndrome causes delay in diagnosis","volume":"39","author":"Mol Debes","year":"2008","journal-title":"Neuropediatrics"},{"key":"key20160120090146612_ref1-bib210","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/mds.20680","article-title":"Gilles de la Tourette syndrome: Patient\u2019s knowledge and concern of adverse effects","volume":"21","author":"Kompoliti","year":"2006","journal-title":"Mov Disord"},{"key":"key20160120090146612_ref1-bib211","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1037\/a0021709","article-title":"Behavior Therapy for Tourette\u2019s Disorder: Utilization in a Community Sample and an Emerging Area of Practice for Psychologists","volume":"41","author":"Woods","year":"2010","journal-title":"Prof Psychol Res Pr"},{"key":"key20160120090146612_ref1-bib212","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10578-010-0211-4","article-title":"Exploring the impact of chronic tic disorders on youth: results from the Tourette Syndrome Impact Survey","volume":"42","author":"Conelea","year":"2011","journal-title":"Child Psychiatry Hum Dev"},{"key":"key20160120090146612_ref1-bib213","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale \u2013 Initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20160120090146612_ref1-bib214","volume-title":"Managing Tourette\u2019s syndrome: A behavioral Intervention for Children and Adults (Therapist Guide)","author":"Woods","year":"2008"},{"key":"key20160120090146612_ref1-bib215","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12888-015-0430-0","article-title":"Perceptions of treatment for tics among young people with Tourette syndrome and their parents: a mixed methods study","volume":"15","author":"Cuenca","year":"2015","journal-title":"BMC Psychiatr"},{"key":"key20160120090146612_ref1-bib216","volume-title":"Transforming Qualitative Information: Thematic Analysis and Code Development","author":"Boyatzis","year":"1998"},{"key":"key20160120090146612_ref1-bib217","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2013","journal-title":"Qual Res Psychol"},{"key":"key20160120090146612_ref1-bib218","volume-title":"Mode Effects in Qualitative Interviews: A Comparison of Semistructured Face-to-Face and Telephone Interviews Using Conversation Analysis, Research Works, 2010\u201303","author":"Irvine","year":"2010"},{"key":"key20160120090146612_ref1-bib219","volume-title":"The Communications Market Report","author":"Ofcom"},{"key":"key20160120090146612_ref1-bib220","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1469-7610.2005.01553.x","article-title":"Barriers to the identification of children with attention deficit\/hyperactivity disorder","volume":"47","author":"Sayal","year":"2006","journal-title":"J Child Psychol Psychiatry"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta20040\/hta20040.xml","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2002379","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/hta20040\/hta20040.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2003385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T22:25:25Z","timestamp":1718317525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/hta20040\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":220,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,1]]}},"alternative-id":["10.3310\/hta20040"],"URL":"https:\/\/doi.org\/10.3310\/hta20040","relation":{},"ISSN":["1366-5278","2046-4924"],"issn-type":[{"value":"1366-5278","type":"print"},{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"}]}}